UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K/A
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): December 17, 2020
Medicine Man Technologies, Inc.
(Exact Name of Registrant as Specified in its Charter)
Nevada | 001-36868 | 46-5289499 | ||
(State or Other Jurisdiction of Incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
4880 Havana Street, Suite 201 Denver, Colorado |
80239 | |
(Address of Principal Executive Offices) | (Zip Code) |
Registrant’s telephone number, including area code (303) 371-0387
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):
[_] | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
[_] | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
[_] | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
[_] | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company [X]
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [X]
Section 2 Financial Information
Item 2.01. Completion of Acquisition or Disposition of Assets.
On December 23, 2020, Medicine Man Technologies, Inc., operating its business under the trade name Schwazze (the “Company”) filed a Form 8-K in connection with the completion of the Asset Purchase Agreements (the “Agreements”) with Starbuds Commerce City, LLC (“Commerce City”) and Lucky Ticket, LLC (“Lucky Ticket”).
This Form 8-K/A amends the Form 8-K the Company filed on December 23, 2020 to include (i) unaudited financial statements as of, and for the nine months ended, September 30, 2020 of Commerce City and Lucky Ticket, (ii) audited financial statements as of, and for the year ended, December 31, 2019 of Commerce City and Lucky Ticket, and (iii) unaudited pro forma condensed combined financial information of the Company giving effect to the Commerce City and Lucky Ticket agreements, required by Items 9.01(a) and 9.01(b) of Form 8-K.
Section 9 Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits.
(a) Financial Statements of Business Acquired
1. The unaudited financial statements of Commerce City and Lucky Ticket and the notes thereto, for the nine months ended September 30, 2020 and 2019, are included as Exhibit 99.1 hereto and are incorporated herein by reference.
2. The audited financial statements of Commerce City and Lucky Ticket and the notes thereto, for the year ended December 31, 2019, are included as Exhibit 99.1 hereto and are incorporated herein by reference.
(b) Pro Forma Financial Information
The following unaudited pro forma condensed combined financial information of the Company, giving effect to the Commerce City and Lucky Ticket Agreements, is included in Exhibit 99.2 hereto and is incorporated herein by reference:
1. Unaudited Pro Forma Condensed Combined Balance Sheet as of September 30, 2020;
2. Unaudited Pro Forma Condensed Combined Statement of Operations for the nine months ended September 30, 2020; and
3. Unaudited Pro Forma Condensed Combined Statement of Operations for the year ended December 31, 2019.
(d) Exhibits
2 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Medicine Man Technologies, Inc. | ||
By: | /s/ Justin Dye | |
Date: March 4, 2021 | Justin Dye, Chief Executive Officer | |
(Principal Executive Officer) | ||
By: | /s/ Nancy Huber | |
Nancy Huber, Chief Financial Officer | ||
(Principal Financial and Accounting Officer) |
3 |
Exhibit 99.1
STARBUDS COMMERCE
CITY LLC
FINANCIAL STATEMENTS
FOR THE NINE MONTHS ENDED
SEPTEMBER 30, 2020 AND 2019 (UNAUDITED)
AND THE YEAR ENDED
DECEMBER 31, 2019
STARBUDS COMMERCE CITY LLC
Index to Financial Statements
Page | |
FINANCIAL STATEMENTS: | |
Independent Auditor’s Report | 1 |
Balance Sheets as of September 30, 2020 (unaudited) and December 31, 2019 | 2 |
Statements of Income for the nine months ended September 30, 2020 and 2019 (unaudited) and the year ended December 31, 2019 | 3 |
Statement of Changes in Members’ Equity for the nine months ended September 30, 2020 and 2019 (unaudited) and the year ended December 31, 2019 | 4 |
Statement of Cash Flows for the nine months ended September 30, 2020 and 2019 (unaudited) and the year ended December 31, 2019 | 5 |
Notes to Financial Statements | 6 |
Crowe LLP Independent Member Crowe Global |
INDEPENDENT AUDITOR’S REPORT
To the Members
Starbuds Commerce City LLC
Commerce City, Colorado
Report on the Financial Statements
We have audited the accompanying financial statements of Starbuds Commerce City LLC (the “Company”), which comprise the balance sheet as of December 31, 2019, and the related statements of income, changes in members’ equity, and cash flows for the year then ended, and the related notes to the financial statements.
Management’s Responsibility for the Financial Statements
Management is responsible for the preparation and fair presentation of these financial statements in accordance with accounting principles generally accepted in the United States of America; this includes the design, implementation, and maintenance of internal control relevant to the preparation and fair presentation of financial statements that are free from material misstatement, whether due to fraud or error.
Auditor’s Responsibility
Our responsibility is to express an opinion on these financial statements based on our audit. We conducted our audit in accordance with auditing standards generally accepted in the United States of America. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free from material misstatement.
An audit involves performing procedures to obtain audit evidence about the amounts and disclosures in the financial statements. The procedures selected depend on the auditor’s judgment, including the assessment of the risks of material misstatement of the financial statements, whether due to fraud or error. In making those risk assessments, the auditor considers internal control relevant to the entity’s preparation and fair presentation of the financial statements in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the entity’s internal control. Accordingly, we express no such opinion. An audit also includes evaluating the appropriateness of accounting policies used and the reasonableness of significant accounting estimates made by management, as well as evaluating the overall presentation of the financial statements.
We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit opinion.
Opinion
In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of the Company as of December 31, 2019 and the results of its operations and its cash flows for the year then ended in accordance with accounting principles generally accepted in the United States of America.
Emphasis of Matter
As discussed in Note 2 to the financial statements, the Company operates in the marijuana industry which is currently illegal under federal law which supersedes any individual state enactments. If the federal government elects to enforce the laws as currently written or otherwise changes the laws in an adverse way with respect to marijuana it could have an adverse effect on the Company’s operations, including potential prosecution under the laws and liquidation of the Company. Our opinion is not modified with respect to this matter.
Crowe LLP
Oak Brook, Illinois
March 4, 2021
1 |
STARBUDS COMMERCE CITY LLC
Balance Sheets
September 30, 2020 | December 31, 2019 | |||||||
(unaudited) | ||||||||
ASSETS | ||||||||
Current Assets: | ||||||||
Cash | $ | 227,073 | $ | 222,692 | ||||
Inventories | 240,576 | 156,288 | ||||||
Prepaid Expenses and Other Current Assets | 7,039 | 10,117 | ||||||
Total Current Assets | 474,688 | 389,097 | ||||||
Property and Equipment, Net | 313,144 | 334,589 | ||||||
TOTAL ASSETS | $ | 787,832 | $ | 723,686 | ||||
LIABILITIES AND MEMBERS’ EQUITY | ||||||||
Liabilities: | ||||||||
Current Liabilities: | ||||||||
Accounts Payable | $ | 5,066 | $ | 5,066 | ||||
Accrued Liabilities | 103,002 | 89,535 | ||||||
Loyalty Points Liability | 80,000 | 72,322 | ||||||
Total Current Liabilities | 188,068 | 166,923 | ||||||
TOTAL LIABILITIES | 188,068 | 166,923 | ||||||
TOTAL MEMBERS' EQUITY | 599,764 | 556,763 | ||||||
. | ||||||||
TOTAL LIABILITIES AND MEMBERS' EQUITY | $ | 787,832 | $ | 723,686 |
Accompanying Notes are an Integral Part of the Financial Statements
2 |
STARBUDS COMMERCE CITY LLC
Statements of Income
Year Ended | ||||||||||||
Nine Months Ended September 30, | December 31, | |||||||||||
2020 | 2019 | 2019 | ||||||||||
(unaudited) | (unaudited) | |||||||||||
Revenues, Net of Discounts | 2,876,996 | $ | 2,438,217 | $ | 3,227,482 | |||||||
Cost of Goods Sold | 1,439,580 | 1,175,548 | 1,603,338 | |||||||||
Gross Profit | 1,437,416 | 1,262,669 | 1,624,144 | |||||||||
Operating Expenses: | ||||||||||||
General and Administrative | 639,837 | 638,530 | 831,218 | |||||||||
Sales and Marketing | 4,536 | 5,006 | 7,956 | |||||||||
Depreciation | 24,042 | 23,991 | 31,988 | |||||||||
Total Operating Expenses | 668,415 | 667,527 | 871,162 | |||||||||
Net Income | $ | 769,001 | $ | 595,142 | $ | 752,982 |
Accompanying Notes are an Integral Part of the Financial Statements
3 |
STARBUDS COMMERCE CITY LLC
Statements of Changes in Members’ Equity
Balance, January 1, 2019 | $ | 582,075 | ||
Net Income | 752,982 | |||
Member Contributions - Star Buds brand license | 258,000 | |||
Distributions to Members | (1,036,294 | ) | ||
Balance, December 31, 2019 | $ | 556,763 | ||
Balance, January 1, 2019 | $ | 582,075 | ||
Net Income (unaudited) | 595,142 | |||
Member Contributions - Star Buds brand license (unaudited) | 195,000 | |||
Distributions to Members (unaudited) | (749,813 | ) | ||
Balance, September 30, 2019 (unaudited) | $ | 622,404 | ||
Balance, January 1, 2020 | $ | 556,763 | ||
Net Income (unaudited) | 769,001 | |||
Member Contributions - Star Buds brand license (unaudited) | 230,000 | |||
Distributions to Members (unaudited) | (956,000 | ) | ||
Balance, September 30, 2020 (unaudited) | $ | 599,764 |
Accompanying Notes are an Integral Part of the Financial Statements
4 |
STARBUDS COMMERCE CITY LLC
Statements of Cash Flows
For the Nine Months Ended | Year Ended | |||||||||||
September 30, | December 31, | |||||||||||
2020 | 2019 | 2019 | ||||||||||
(unaudited) | (unaudited) | |||||||||||
CASH FLOWS FROM OPERATING ACTIVITIES: | ||||||||||||
Net Income | $ | 769,001 | $ | 595,142 | $ | 752,982 | ||||||
Adjustments to Reconcile Net Income to Net Cash Provided by Operating Activities | ||||||||||||
Depreciation | 24,042 | 23,991 | 31,988 | |||||||||
Star Buds brand license expense | 230,000 | 195,000 | 258,000 | |||||||||
Changes in Operating Assets and Liabilities: | ||||||||||||
Inventories | (84,288 | ) | (76,033 | ) | (27,169 | ) | ||||||
Prepaid Expenses and Other Current Assets | 3,078 | 12,642 | 13,009 | |||||||||
Accounts Payable | – | – | 5,066 | |||||||||
Accrued Liabilities | 13,467 | (13,980 | ) | 10,820 | ||||||||
Loyalty Points Liability | 7,678 | – | 19,327 | |||||||||
NET CASH PROVIDED BY OPERATING ACTIVITIES | 962,978 | 736,762 | 1,064,023 | |||||||||
CASH FLOWS FROM INVESTING ACTIVITIES: | ||||||||||||
Purchases of Property and Equipment | (2,597 | ) | – | – | ||||||||
NET CASH USED IN INVESTING ACTIVITIES | (2,597 | ) | – | – | ||||||||
CASH FLOWS FROM FINANCING ACTIVITIES: | ||||||||||||
Distributions to Members | (956,000 | ) | (749,813 | ) | (1,036,294 | ) | ||||||
NET CASH USED IN FINANCING ACTIVITIES | (956,000 | ) | (749,813 | ) | (1,036,294 | ) | ||||||
NET INCREASE (DECREASE) IN CASH | 4,381 | (13,051 | ) | 27,729 | ||||||||
CASH, BEGINNING OF PERIOD | 222,692 | 194,963 | 194,963 | |||||||||
CASH, END OF PERIOD | $ | 227,073 | $ | 181,912 | $ | 222,692 |
Accompanying Notes are an Integral Part of the Financial Statements
5 |
STARBUDS COMMERCE CITY LLC
Notes to Financial Statements
For the Nine Months Ended September 30, 2020 and 2019 (unaudited)
and the Year Ended December 31, 2019
1. NATURE OF OPERATIONS
Starbuds Commerce City LLC (the “Company”) owns and operates a recreational marijuana dispensary in Commerce City, Colorado. The dispensary sells a variety of products including buds, extracts, and edibles.
In June 2020, the Company entered into an asset purchase agreement with Medicine Man Technologies, Inc., for total consideration of approximately $7,200,000, which includes cash, deferred cash and shares in Medicine Man Technologies, Inc. The transaction closed in December 2020.
2. SIGNIFICANT ACCOUNTING POLICIES
(a) Basis of Preparation
The accompanying financial statements are presented in accordance with accounting principles generally accepted in the United States of America. The accompanying financial statements include unaudited interim information as of September 30, 2020 and for the nine months ended September 30, 2020 and 2019. The interim information is not reflective of full year results. Company management believes the interim information includes all normal recurring adjustments.
(b) Revenue
Revenue is recognized at the point of sale, at which time title and risk of loss pass to the customers. The Company has customer loyalty programs in which retail customers accumulate points for each dollar of spending. These points are recorded as a contract liability until customers redeem their points for discounts on cannabis and vape products as part of an in-store sales transaction
(c) Cash
Cash includes cash deposits in financial institutions and cash held at the store.
(d) Inventories
Inventories consist of cannabis and non-cannabis products that are valued at cost and subsequently at the lower of cost (first-in, first out basis) or net realizable value. The Company reviews its inventories for obsolete, redundant and slow-moving goods and any such inventories are written down to net realizable value. There were no reserves for obsolete inventories as of September 30, 2020 and December 31, 2019.
6 |
STARBUDS COMMERCE CITY LLC
Notes to Financial Statements
For the Nine Months Ended September 30, 2020 and 2019 (unaudited)
and the Year Ended December 31, 2019
2. SIGNIFICANT ACCOUNTING POLICIES (Continued)
(e) Property and Equipment
Property and equipment is stated at cost, net of accumulated depreciation and impairment losses, if any. Expenditures that materially increase the life of the assets are capitalized. Ordinary repairs and maintenance are expensed as incurred. Depreciation is calculated on a straight-line basis over the estimated useful life of the asset using the following terms and methods.
Leasehold Improvements | Shorter of Remaining Life of the Lease or Useful Life |
Furniture and Fixtures |
5 - 7 Years |
Computer Equipment | 5 Years |
The assets’ carrying values, useful lives and methods of depreciation are reviewed at each financial year-end and adjusted prospectively if appropriate. An item of property and equipment is derecognized upon disposal or when no future economic benefits are expected from its use. Any gain or loss arising on derecognition of the asset (calculated as the difference between the net disposal proceeds and the carrying value of the asset) is included in the Statements of Income in the year the asset is derecognized.
(f) | Impairment of Long-Lived Assets |
The Company accounts for its long-lived assets such as property and equipment in accordance with FASB ASC Topic No. 360, "Accounting for the Impairment or Disposal of Long-lived Assets" ("ASC 360").
Management reviews long-lived assets for impairment whenever changes in events or circumstances indicate the assets may be impaired. Pursuant to ASC 360, an impairment loss is to be recorded when the net book value of an asset exceeds the undiscounted cash flows expected to be generated from the use of the asset. If an asset is determined to be impaired, the asset is written down to its fair value, and the loss is recognized in the statement of income in the period when the determination is made. No impairment charges for long-lived assets have been recorded for the year ended December 31, 2019 or the nine months ended September 30, 2020 and 2019.
(g) | Leased Assets |
A lease of property and equipment is classified as a capital lease if it transfers substantially all the risks and rewards incidental to ownership to the Company. A lease of property and equipment is classified as an operating lease whenever the terms of the lease do not transfer substantially all of the risks and rewards of ownership to the lessee. Lease payments are recognized as an expense on a straight-line basis over the lease term, except where another systematic basis is more representative of the time pattern in which the economic benefits are consumed.
7 |
STARBUDS COMMERCE CITY LLC
Notes to Financial Statements
For the Nine Months Ended September 30, 2020 and 2019 (unaudited)
and the Year Ended December 31, 2019
2. SIGNIFICANT ACCOUNTING POLICIES (Continued)
(h) | Income Taxes |
The Company’s members have elected to have the Company treated as a partnership for income tax purposes. As such, all the Company’s items of income, loss, deduction, and credit are passed through to, and taken into account by, the Company’s members in computing their own taxable income.
As the Company operates in the cannabis industry, it is subject to the limits of IRC Section 280E under which the Company is only allowed to deduct expenses directly related to sales of product. This results in permanent differences between ordinary and necessary business expenses deemed non-allowable under IRC Section 280E. The Company’s policy is to recognize interest and penalties accrued on any unrecognized tax position as a component of income tax expense. As of September 30, 2020 and December 31, 2019, the Company did not have any accrued interest or penalties associated with any unrecognized tax positions, nor was any interest or penalties recognized during the year ended December 31, 2019 or nine months ended September 30, 2020 and 2019.
(i) | Fair Value Measurement |
The carrying amounts of cash and accounts payable approximate fair value due to the short maturity of these instruments.
(j) | Significant Accounting Judgments, Estimates, and Assumptions |
The preparation of the Company’s financial statements requires management to make judgments, estimates and assumptions that affect the application of policies and reported amounts of assets and liabilities, and revenue and expenses. Actual results may differ from these estimates. The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the period in which the estimate is revised if the revision affects only that period or in the period of the revision and future periods if the revision affects both current and future periods.
Significant estimates inherent in the preparation of the Company’s financial statements include the assumptions related to the valuation of inventory, the valuation and estimated useful lives for property and equipment and the loyalty program liability.
The Company’s business is subject to a variety of state laws, regulations, and local ordinances. Certain states have legalized the possession, distribution, and cultivation of marijuana for medical and/or non-medical purposes; these activities remain illegal under federal law, which cause higher federal income taxation (IRC Section 280E) and difficulty in obtaining traditional banking relationships. If the federal government elects to enforce the laws as currently written or otherwise changes the laws in an adverse way with respect to marijuana it could have an adverse effect on the Company’s operations, including potential prosecution under the laws and liquidation of the Company.
8 |
STARBUDS COMMERCE CITY LLC
Notes to Financial Statements
For the Nine Months Ended September 30, 2020 and 2019 (unaudited)
and the Year Ended December 31, 2019
2. | SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued) |
(k) | Concentrations of Credit Risk |
The Company’s financial instruments that at times are exposed to concentrations of credit risk consist primarily of cash. The Company maintains cash in bank accounts, which at times may exceed federally insured limits. The Company has not experienced any losses in such accounts. Management does not believe the Company is exposed to significant credit risk related to cash because the Company maintains cash with high quality institutions.
(l) | Recent Accounting Pronouncements |
(i) | The FASB issued ASU 2014-09, Revenue from Contracts with Customers, (Topic 606) (ASU 2014-09), in May 2014. ASU 2014-09 sets forth a new five-step revenue recognition model that will require the use of more estimates and judgment. ASU 2014-09 will replace current revenue recognition requirements in Topic 605, Revenue Recognition, in its entirety. The standard also requires more detailed disclosures and provides additional guidance for transactions that were not addressed completely in prior accounting guidance. In May 2020, the FASB deferred the effective date of ASU 2014-09 making it effective for annual financial statements of private companies issued for fiscal years beginning after December 15, 2019 and interim periods within fiscal years beginning after December 15, 2020, and should be applied retrospectively in the year the ASU is first applied using one of two allowable application methods. The Company is currently evaluating the effect of adopting this ASU on the Company’s financial statements but does not believe the impact will be material. |
(ii) | In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842) (“ASC 842”), which will replace ASC 840, “Leases”. This standard introduces a single lessee accounting model and requires a lessee to recognize assets and liabilities for all leases with a term of more than twelve months. A lessee is required to recognize a right-of-use asset representing its right to use the underlying asset and a lease liability representing its obligation to make lease payments. For private companies, the standard will be effective for annual periods beginning on or after December 15, 2021, with earlier application permitted. The standard requires a modified retrospective approach for leases that exist or are entered into after the beginning of the earliest comparative period in the financial statements. The Company is currently evaluating the effect of adopting this ASU on the Company’s financial statements. |
(iii) | In June 2016, FASB issued ASC 2016-13, Financial Instruments – Credit Losses (Topic 326), Measurement of Credit Losses on Financial Instruments. ASU 2016-13 requires entities to measure all expected credit losses for most financial assets held at the reporting date based on an expected loss model which includes historical experience, current conditions, an reasonable and supportable forecasts. Companies will now use forward-looking information to better form their credit loss estimates. ASU 2016-13 also requires enhanced disclosures to help financial statement users better understand significant estimates and judgements used in estimating credit losses, as well as the credit quality and underwriting standards of a company’s portfolio. For private companies, ASU 2016-13 is effective for annual periods beginning after December 15, 2022. The Company does not believe that the impact of the new standard on its financial statements will be material. |
3. PROPERTY AND EQUIPMENT
The Company’s property and equipment consists of the following at September 30, 2020 and December 31, 2019:
9 |
STARBUDS COMMERCE CITY LLC
Notes to Financial Statements
For the Nine Months Ended September 30, 2020 and 2019 (unaudited)
and the Year Ended December 31, 2019
September 30, | December 31, | |||||||
2020 | 2019 | |||||||
(unaudited) | ||||||||
Leasehold Improvements | $ | 388,276 | $ | 385,680 | ||||
Furniture and Fixtures | 30,423 | 30,423 | ||||||
Computer Equipment | 6,825 | 6,825 | ||||||
Total Property and Equipment, Gross | 425,524 | 422,928 | ||||||
Less: Accumulated Depreciation | (112,380 | ) | (88,339 | ) | ||||
Property and Equipment, Net | $ | 313,144 | $ | 334,589 |
Depreciation expense for the year ended December 31, 2019 and the nine months ended September 30, 2020 and 2019 totaled $31,988, 24,022, and 23,991, respectively.
4. | MEMBERS’ EQUITY |
Under the terms of the operating agreement, the Company has an indefinite life. Allocations of profits and losses for each fiscal year are allocated pro rata in proportion to the member’s capital interest. Distributions shall be made to members in proportion to the member’s capital interest and are approved by the manager of the Company in accordance with the terms of the operating agreement.
5. LEASE COMMITMENTS
The Company leases its business facility from a related party under an operating lease agreement that specifies minimum rentals. The lease expires in 2023. The Company’s rent expense for the year ended December 31, 2019 and the nine months ended September 30, 2020 and 2019 was approximately $60,000, $45,000, and $45,000, respectively.
Future minimum lease payments under non-cancelable operating leases having an initial or remaining term of more than one year are as follows:
Year Ending December 31 | Total | ||||
2020 (remaining three months) | $ | 15,000 | |||
2021 | 60,000 | ||||
2022 | 60,000 | ||||
2023 | 15,000 | ||||
$ | 150,000 |
10 |
STARBUDS COMMERCE CITY LLC
Notes to Financial Statements
For the Nine Months Ended September 30, 2020 and 2019 (unaudited)
and the Year Ended December 31, 2019
6. | COMMITMENTS AND CONTINGENCIES |
(a) Claims and Litigation
From time to time, the Company may be involved in litigation relating to claims arising out of operations in the normal course of business. At September 30, 2020, there were no pending or threatened lawsuits that could reasonably be expected to have a material effect on the results of the Company’s operations. There are also no proceedings in which any of the Company’s directors, officers or affiliates is an adverse party or has a material interest adverse to the Company’s interest.
(b) Contingencies
The Company's operations are subject to a variety of local and state regulation. Failure to comply with one or more of those regulations could result in fines, restrictions on its operations, or losses of permits that could result in the Company ceasing operations. While management of the Company believes that the Company is in compliance with applicable local and state regulation at September 30, 2020, cannabis regulations continue to evolve and are subject to differing interpretations. As a result, the Company may be subject to regulatory fines, penalties, or restrictions in the future.
7. | RELATED PARTY TRANSACTIONS |
(a) Transactions with related parties
The Company purchases product from several related parties, CitiMed LLC, Colorado Health Consultants, LLC, Starbuds MIPS LLC, and Star Packaging and Supply LLC. The Company receives management, advisory and marketing support services from Star Packaging and Supply LLC. Amounts expensed and paid to each related party for the year ended December 31, 2019 and the nine months ended September 30, 2020 and 2019 were as follows.
Year Ended | ||||||||||||
Nine Months Ended September 30, | December 31, | |||||||||||
2020 | 2019 | 2019 | ||||||||||
(unaudited) | (unaudited) | |||||||||||
CitiMed, LLC | $ | 70,000 | $ | 55,000 | $ | 80,000 | ||||||
Colorado Health Consultants, LLC | 50,000 | – | 5,000 | |||||||||
Starbuds MIPS LLC | 110,000 | 111,000 | 155,000 | |||||||||
Star Packaging and Supply LLC | 65,000 | 85,000 | 112,000 | |||||||||
Total | $ | 295,000 | $ | 251,000 | $ | 352,000 |
Purchases from Starbuds MIPS LLC were approximately 11% of the Company’s purchases for the year ended December 31, 2019.
Star Brands, LLC provides the Company with the right to use the Starbuds brand and licensed property. The Company does not pay Star Brands LLC for the use of such assets. However, the Company recorded non-cash license expense of $258,000 for the year ended December 31, 2019 and $230,000 and $195,000 for the nine months ended September 30, 2020 and 2019, respectively.
(b) Related party leases
The Company has a lease for a facility with an entity owned by a member of the Company (see note 5).
11 |
STARBUDS COMMERCE CITY LLC
Notes to Financial Statements
For the Nine Months Ended September 30, 2020 and 2019 (unaudited)
and the Year Ended December 31, 2019
8. SUBSEQUENT EVENTS
Management has evaluated significant events or transactions that have occurred since the balance sheet date and through March 3, 2021, the date the financial statements were available to be issued.
The novel coronavirus commonly referred to as “COVID-19” was identified in December 2019 in Wuhan, China. On January 30, 2020, the World Health Organization declared the outbreak a global health emergency, and on March 11, 2020, the spread of COVID-19 was declared a pandemic by the World Health Organization. On March 13, 2020, the spread of COVID-19 was declared a national emergency. The outbreak has spread throughout the globe, causing companies and various international jurisdictions to impose restrictions such as quarantines, business closures and travel restrictions.
While these effects are expected to be temporary, the duration of the business disruptions and related financial impact cannot reasonably be estimated at this time. In addition, it is possible that estimates in the Company’s financial statements will change in the near term as a result of COVID-19 and the effect of any such changes could be material, which could result in, among other things, impairment of long-lived assets. The Company is closely monitoring the impact of the pandemic on all aspects of its business.
In response to the COVID-19 pandemic and government mandates, safety, social distancing and other physical workforce distancing protocols were implemented. Although the impact of the coronavirus on the Companies’ operations to date has not been significant, the ultimate impact of COVID-19 on the Companies will depend on future developments, which are highly uncertain and cannot be predicted, including new information which may emerge concerning the severity of COVID-19 and the actions required to contain the coronavirus or treat its impact, among others.
As described in Note 1, the Company was acquired by Medicine Man Technologies, Inc.
Subsequent to December 31, 2019, the Company distributed approximately $3,900,000 to its members.
12 |
LUCKY TICKET LLC
FINANCIAL STATEMENTS
FOR THE NINE MONTHS ENDED
SEPTEMBER 30, 2020 AND 2019 (UNAUDITED)
AND THE YEAR ENDED
DECEMBER 31, 2019
13 |
LUCKY TICKET LLC
Index to Financial Statements
Page | |
FINANCIAL STATEMENTS: | |
Independent Auditor’s Report | 15 |
Balance Sheets as of September 30, 2020 (unaudited) and December 31, 2019 | 16 |
Statements of Income for the nine months ended September 30, 2020 and 2019 (unaudited) and the year ended December 31, 2019 | 17 |
Statement of Changes in Members’ Equity for the nine months ended September 30, 2020 and 2019 (unaudited) and the year ended December 31, 2019 | 18 |
Statement of Cash Flows for the nine months ended September 30, 2020 and 2019 (unaudited) and the year ended December 31, 2019 | 19 |
Notes to Financial Statements | 20 |
14 |
Crowe LLP Independent Member Crowe Global |
INDEPENDENT AUDITOR’S REPORT
To the Members
Lucky Ticket LLC
Denver, Colorado
Report on the Financial Statements
We have audited the accompanying financial statements of Lucky Ticket LLC (the “Company”), which comprise the balance sheet as of December 31, 2019, and the related statements of income, changes in members’ equity, and cash flows for the year then ended, and the related notes to the financial statements.
Management’s Responsibility for the Financial Statements
Management is responsible for the preparation and fair presentation of these financial statements in accordance with accounting principles generally accepted in the United States of America; this includes the design, implementation, and maintenance of internal control relevant to the preparation and fair presentation of financial statements that are free from material misstatement, whether due to fraud or error.
Auditor’s Responsibility
Our responsibility is to express an opinion on these financial statements based on our audit. We conducted our audit in accordance with auditing standards generally accepted in the United States of America. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free from material misstatement.
An audit involves performing procedures to obtain audit evidence about the amounts and disclosures in the financial statements. The procedures selected depend on the auditor’s judgment, including the assessment of the risks of material misstatement of the financial statements, whether due to fraud or error. In making those risk assessments, the auditor considers internal control relevant to the entity’s preparation and fair presentation of the financial statements in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the entity’s internal control. Accordingly, we express no such opinion. An audit also includes evaluating the appropriateness of accounting policies used and the reasonableness of significant accounting estimates made by management, as well as evaluating the overall presentation of the financial statements.
We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit opinion.
Opinion
In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of the Company as of December 31, 2019 and the results of its operations and its cash flows for the year then ended in accordance with accounting principles generally accepted in the United States of America.
Emphasis of Matter
As discussed in Note 2 to the financial statements, the Company operates in the marijuana industry which is currently illegal under federal law which supersedes any individual state enactments. If the federal government elects to enforce the laws as currently written or otherwise changes the laws in an adverse way with respect to marijuana it could have an adverse effect on the Company’s operations, including potential prosecution under the laws and liquidation of the Company. Our opinion is not modified with respect to this matter.
Crowe LLP
Oak Brook, Illinois
March 4, 2021
15 |
LUCKY TICKET LLC
Balance Sheets
September 30, 2020 | December 31, 2019 | |||||||
(unaudited) | ||||||||
ASSETS | ||||||||
Current Assets: | ||||||||
Cash | $ | 148,250 | $ | 252,359 | ||||
Inventories | 168,719 | 196,310 | ||||||
Total Current Assets | 316,969 | 448,669 | ||||||
Property and Equipment, Net | 73,618 | 79,873 | ||||||
Other Assets | 5,400 | 5,400 | ||||||
TOTAL ASSETS | $ | 395,987 | $ | 533,942 | ||||
LIABILITIES AND MEMBERS’ EQUITY | ||||||||
Liabilities: | ||||||||
Current Liabilities: | ||||||||
Checks Issued in Excess of Bank Balance | $ | 18,529 | $ | 45,977 | ||||
Accrued Liabilities | 106,480 | 127,271 | ||||||
Loyalty Points Liability | 130,000 | 125,017 | ||||||
Total Current Liabilities | 255,009 | 298,265 | ||||||
TOTAL LIABILITIES | 255,009 | 298,265 | ||||||
TOTAL MEMBERS' EQUITY | 140,978 | 235,677 | ||||||
TOTAL LIABILITIES AND MEMBERS' EQUITY | $ | 395,987 | $ | 533,942 |
Accompanying Notes are an Integral Part of the Financial Statements
16 |
LUCKY TICKET LLC
Statements of Income
Year Ended | ||||||||||||
Nine Months Ended September 30, | December 31, | |||||||||||
2020 | 2019 | 2019 | ||||||||||
(unaudited) | (unaudited) | |||||||||||
Revenues, Net of Discounts | $ | 4,562,094 | $ | 4,275,770 | $ | 5,656,049 | ||||||
Cost of Goods Sold | 2,270,708 | 1,972,639 | 2,535,833 | |||||||||
Gross Profit | 2,291,386 | 2,303,131 | 3,120,216 | |||||||||
Expenses: | ||||||||||||
General and Administrative | 837,924 | 770,961 | 1,037,839 | |||||||||
Sales and Marketing | 16,138 | 15,528 | 17,514 | |||||||||
Depreciation | 6,255 | 5,786 | 7,714 | |||||||||
Total Expenses | 860,317 | 792,275 | 1,063,067 | |||||||||
Net Income | $ | 1,431,069 | $ | 1,510,856 | $ | 2,057,149 |
Accompanying Notes are an Integral Part of the Financial Statements
17 |
LUCKY TICKET LLC
Statements of Changes in Members’ Equity
Balance, January 1, 2019 | $ | 62,594 | ||
Net Income | 2,057,149 | |||
Member Contributions - Star Buds brand license | 452,000 | |||
Distributions to Members | (2,336,066 | ) | ||
Balance, December 31, 2019 | $ | 235,677 | ||
Balance, January 1, 2019 | $ | 62,594 | ||
Net Income (unaudited) | 1,510,856 | |||
Member Contributions - Star Buds brand license (unaudited) | 342,000 | |||
Distributions to Members (unaudited) | (1,852,993 | ) | ||
Balance, September 30, 2019 | $ | 62,457 | ||
Balance, January 1, 2020 | $ | 235,677 | ||
Net Income (unaudited) | 1,431,069 | |||
Member Contributions - Star Buds brand license (unaudited) | 365,000 | |||
Distributions to Members (unaudited) | (1,890,768 | ) | ||
Balance, September 30, 2020 (unaudited) | $ | 140,978 |
Accompanying Notes are an Integral Part of the Financial Statements
18 |
LUCKY TICKET LLC
Statements of Cash Flows
For the Nine Months Ended | Year Ended | |||||||||||
September 30, | December 31, | |||||||||||
2020 | 2019 | 2019 | ||||||||||
(unaudited) | (unaudited) | |||||||||||
CASH FLOWS FROM OPERATING ACTIVITIES: | ||||||||||||
Net Income | $ | 1,431,069 | $ | 1,510,856 | $ | 2,057,149 | ||||||
Adjustments to Reconcile Net Income to Net Cash | ||||||||||||
Provided by Operating Activities | ||||||||||||
Depreciation | 6,255 | 5,786 | 7,714 | |||||||||
Star Buds brand license expense | 365,000 | 342,000 | 452,000 | |||||||||
Changes in Operating Assets and Liabilities: | ||||||||||||
Inventories | 27,591 | (37,576 | ) | (96,532 | ) | |||||||
Checks Issued in Excess of Bank Balance | (27,448 | ) | (64,018 | ) | (35,077 | ) | ||||||
Accounts Payable | – | 107,000 | – | |||||||||
Accrued Liabilities | (20,791) | 199 | 33,158 | |||||||||
Loyalty Points Liability | 4,983 | – | 2,759 | |||||||||
NET CASH PROVIDED BY OPERATING ACTIVITIES | 1,786,659 | 2,031,246 | 2,421,171 | |||||||||
CASH FLOWS FROM INVESTING ACTIVITIES: | ||||||||||||
Purchases of Property and Equipment | – | (1,856 | ) | (1,856 | ) | |||||||
NET CASH USED IN INVESTING ACTIVITIES | – | (1,856 | ) | (1,856 | ) | |||||||
CASH FLOWS FROM FINANCING ACTIVITIES: | ||||||||||||
Distributions to Members | (1,890,768 | ) | (1,852,993 | ) | (2,336,066 | ) | ||||||
NET CASH USED IN FINANCING ACTIVITIES | (1,890,768 | ) | (1,852,993 | ) | (2,336,066 | ) | ||||||
NET INCREASE (DECREASE) IN CASH | (104,109) | ) | 9,397 | 83,249 | ||||||||
CASH, BEGINNING OF PERIOD | 252,359 | 169,110 | 169,110 | |||||||||
CASH, END OF PERIOD | $ | 148,250 | $ | 178,507 | $ | 252,359 |
Accompanying Notes are an Integral Part of the Financial Statements
19 |
LUCKY TICKET LLC
Notes to Financial Statements
For the Nine Months Ended September 30, 2020 and 2019 (unaudited)
And the Year Ended December 31, 2019
1. NATURE OF OPERATIONS
Lucky Ticket LLC (the “Company”) owns and operates a recreational marijuana dispensary in Denver, Colorado. The dispensary sells a variety of products including buds, extracts, and edibles.
In June 2020, the Company entered into an asset purchase agreement with Medicine Man Technologies, Inc., for total consideration of approximately $11,300,000, which includes cash, deferred cash and shares in Medicine Man Technologies, Inc. The transaction closed in December 2020.
2. SIGNIFICANT ACCOUNTING POLICIES
(a) | Basis of Preparation | |
The accompanying financial statements are presented in accordance with accounting principles generally accepted in the United States of America. The accompanying financial statements include unaudited interim information as of September 30, 2020 and for the nine months ended September 30, 2020 and 2019. The interim information is not reflective of full year results. Company management believes the interim information includes all normal recurring adjustments. | ||
(b) | Revenue | |
Revenue is recognized at the point of sale, at which time title and risk of loss pass to the customers. The Company has customer loyalty programs in which retail customers accumulate points for each dollar of spending. These points are recorded as a contract liability until customers redeem their points for discounts on cannabis and vape products as part of an in-store sales transaction | ||
(c) | Cash | |
Cash includes cash deposits in financial institutions and cash held at the store. | ||
(d) | Inventories | |
Inventories consist of cannabis and non-cannabis products that are valued at cost and subsequently at the lower of cost (first-in, first-out basis) or net realizable value. The Company reviews its inventories for obsolete, redundant and slow-moving goods and any such inventories are written down to net realizable value. There were no reserves for obsolete inventories as of September 30, 2020 and December 31, 2019. |
20 |
LUCKY TICKET LLC
Notes to Financial Statements
For the Nine Months Ended September 30, 2020 and 2019 (unaudited)
And the Year Ended December 31, 2019
2. SIGNIFICANT ACCOUNTING POLICIES (Continued)
(e) | Property and Equipment | |
Property and equipment is stated at cost, net of accumulated depreciation and impairment losses, if any. Expenditures that materially increase the life of the assets are capitalized. Ordinary repairs and maintenance are expensed as incurred. Depreciation is calculated on a straight-line basis over the estimated useful life of the asset using the following terms and methods. |
Leasehold Improvements | Shorter of Remaining Life of the Lease or Useful Life |
Equipment |
7 Years |
Furniture and Fixtures | 7 Years |
The assets’ carrying values, useful lives and methods of depreciation are reviewed at each financial year-end and adjusted prospectively if appropriate. An item of property and equipment is derecognized upon disposal or when no future economic benefits are expected from its use. Any gain or loss arising on derecognition of the asset (calculated as the difference between the net disposal proceeds and the carrying value of the asset) is included in the Statement of Income in the year the asset is derecognized.
(f) | Impairment of Long-Lived Assets |
The Company accounts for its long-lived assets such as property and equipment in accordance with FASB ASC Topic No. 360, "Accounting for the Impairment or Disposal of Long-lived Assets" ("ASC 360").
Management reviews long-lived assets for impairment whenever changes in events or circumstances indicate the assets may be impaired. Pursuant to ASC 360, an impairment loss is to be recorded when the net book value of an asset exceeds the undiscounted cash flows expected to be generated from the use of the asset. If an asset is determined to be impaired, the asset is written down to its fair value, and the loss is recognized in the statement of income in the period when the determination is made. No impairment charges for long-lived assets have been recorded for the year ended December 31, 2019 or the nine months ended September 30, 2020 and 2019.
(g) | Leased Assets |
A lease of property and equipment is classified as a capital lease if it transfers substantially all the risks and rewards incidental to ownership to the Company. A lease of property and equipment is classified as an operating lease whenever the terms of the lease do not transfer substantially all of the risks and rewards of ownership to the lessee. Lease payments are recognized as an expense on a straight-line basis over the lease term, except where another systematic basis is more representative of the time pattern in which the economic benefits are consumed.
(h) | Income Taxes |
The Company’s members have elected to have the Company treated as a partnership for income tax purposes. As such, all the Company’s items of income, loss, deduction, and credit are passed through to, and taken into account by, the Company’s members in computing their own taxable income.
As the Company operates in the cannabis industry, it is subject to the limits of IRC Section 280E under which the Company is only allowed to deduct expenses directly related to sales of product. This results in permanent differences between ordinary and necessary business expenses deemed non-allowable under IRC Section 280E.
21 |
LUCKY TICKET LLC
Notes to Financial Statements
For the Nine Months Ended September 30, 2020 and 2019 (unaudited)
And the Year Ended December 31, 2019
2. SIGNIFICANT ACCOUNTING POLICIES (Continued)
(h) | Income Taxes (Continued) |
The Company’s policy is to recognize interest and penalties accrued on any unrecognized tax position as a component of income tax expense. As of September 30, 2020 and December 31, 2019, the Company did not have any accrued interest or penalties associated with any unrecognized tax positions, nor was any interest or penalties recognized during the year ended December 31, 2019 or nine months ended September 30, 2020 and 2019.
(i) | Fair Value Measurement |
The carrying amount of cash approximates fair value due to the short maturity of these instruments
(j) | Significant Accounting Judgments, Estimates, and Assumptions |
The preparation of the Company’s financial statements requires management to make judgments, estimates and assumptions that affect the application of policies and reported amounts of assets and liabilities, and revenue and expenses. Actual results may differ from these estimates. The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the period in which the estimate is revised if the revision affects only that period or in the period of the revision and future periods if the revision affects both current and future periods.
Significant estimates inherent in the preparation of the Company’s financial statements include the assumptions related to the valuation of inventory, the valuation and estimated useful lives for property and equipment and the loyalty program liability.
The Company’s business is subject to a variety of state laws, regulations, and local ordinances. Certain states have legalized the possession, distribution, and cultivation of marijuana for medical and/or non-medical purposes; these activities remain illegal under federal law, which cause higher federal income taxation (IRC Section 280E) and difficulty in obtaining traditional banking relationships. If the federal government elects to enforce the laws as currently written or otherwise changes the laws in an adverse way with respect to marijuana it could have an adverse effect on the Company’s operations, including potential prosecution under the laws and liquidation of the Company
(k) | Concentrations of Credit Risk |
The Company’s financial instruments that at times are exposed to concentrations of credit risk consist primarily of cash. The Company maintains cash in bank accounts, which at times may exceed federally insured limits. The Company has not experienced any losses in such accounts. Management does not believe the Company is exposed to significant credit risk related to cash because the Company maintains cash with high quality institutions.
22 |
LUCKY TICKET LLC
Notes to Financial Statements
For the Nine Months Ended September 30, 2020 and 2019 (unaudited)
And the Year Ended December 31, 2019
2. SIGNIFICANT ACCOUNTING POLICIES (Continued)
(l) | Recent Accounting Pronouncements |
(i) | The FASB issued ASU 2014-09, Revenue from Contracts with Customers, (Topic 606) (ASU 2014-09), in May 2014. ASU 2014-09 sets forth a new five-step revenue recognition model that will require the use of more estimates and judgment. ASU 2014-09 will replace current revenue recognition requirements in Topic 605, Revenue Recognition, in its entirety. The standard also requires more detailed disclosures and provides additional guidance for transactions that were not addressed completely in prior accounting guidance. In May 2020, the FASB deferred the effective date of ASU 2014-09 making it effective for annual financial statements of private companies issued for fiscal years beginning after December 15, 2019 and interim periods within fiscal years beginning after December 15, 2020, and should be applied retrospectively in the year the ASU is first applied using one of two allowable application methods. The Company is currently evaluating the effect of adopting this ASU on the Company’s financial statements but does not believe the impact will be material. |
(ii) | In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842) (“ASC 842”), which will replace ASC 840, “Leases”. This standard introduces a single lessee accounting model and requires a lessee to recognize assets and liabilities for all leases with a term of more than twelve months. A lessee is required to recognize a right-of-use asset representing its right to use the underlying asset and a lease liability representing its obligation to make lease payments. For private companies, the standard will be effective for annual periods beginning on or after December 15 2021, with earlier application permitted. The standard requires a modified retrospective approach for leases that exist or are entered into after the beginning of the earliest comparative period in the financial statements. The Company is currently evaluating the effect of adopting this ASU on the Company’s financial statements. |
(iii) | In June 2016, FASB issued ASC 2016-13, Financial Instruments – Credit Losses (Topic 326), Measurement of Credit Losses on Financial Instruments. ASU 2016-13 requires entities to measure all expected credit losses for most financial assets held at the reporting date based on an expected loss model which includes historical experience, current conditions, and reasonable and supportable forecasts. Companies will now use forward-looking information to better form their credit loss estimates. ASU 2016-13 also requires enhanced disclosures to help financial statement users better understand significant estimates and judgements used in estimating credit losses, as well as the credit quality and underwriting standards of a company’s portfolio. For private companies, ASU 2016-13 is effective for annual periods beginning after December 15, 2022. The Company does not believe that the impact of the new standard on its financial statements will be material. |
23 |
LUCKY TICKET LLC
Notes to Financial Statements
For the Nine Months Ended September 30, 2020 and 2019 (unaudited)
And the Year Ended December 31, 2019
3. PROPERTY AND EQUIPMENT
The Company’s property and equipment consists of the following at September 30, 2020 and December 31, 2019:
September 30, | December 31, | |||||||
2020 | 2019 | |||||||
(unaudited) | ||||||||
Leasehold Improvements | $ | 101,150 | $ | 101,150 | ||||
Equipment | 7,530 | 7,530 | ||||||
Furniture and Fixtures | 5,295 | 5,295 | ||||||
Total Property and Equipment, Gross | 113,975 | 113,975 | ||||||
Less: Accumulated Depreciation | (40,357 | ) | (34,102 | ) | ||||
Property and Equipment, Net | $ | 73,618 | $ | 79,873 |
Depreciation expense for the year ended December 31, 2019 and the nine months ended September 30, 2020 and 2019 totaled $7,714, $6,255, and $5,786, respectively.
4. | MEMBERS’ EQUITY |
Under the terms of the operating agreement, the Company has an indefinite life. Allocations of profits and losses for each fiscal year are allocated pro rata in proportion to the member’s capital interest. Distributions shall be made to members in proportion to the member’s capital interest and are approved by the manager of the Company in accordance with the terms of the operating agreement.
5. LEASE COMMITMENTS
The Company leases its business facility from a third party under an operating lease agreement that specifies minimum rentals. The lease expires in 2025 and has a renewal option for an additional five years. The Company’s rent expense for the year ended December 31, 2019 and the nine months ended September 30, 2020 and 2019 was approximately $75,000, $65,000, and $57,000, respectively.
Future minimum lease payments under non-cancelable operating leases having an initial or remaining term of more than one year are as follows:
Year Ending December 31 | Total | ||||
2020 (three months remaining) | $ | 18,739 | |||
2021 | 76,058 | ||||
2022 | 77,980 | ||||
2023 | 80,738 | ||||
2024 | 84,175 | ||||
2025 | 35,682 | ||||
$ | 373,372 |
24 |
LUCKY TICKET LLC
Notes to Financial Statements
For the Nine Months Ended September 30, 2020 and 2019 (unaudited)
And the Year Ended December 31, 2019
6. | COMMITMENTS AND CONTINGENCIES |
(a) | Claims and Litigation |
From time to time, the Company may be involved in litigation relating to claims arising out of operations in the normal course of business. At September 30, 2020, there were no pending or threatened lawsuits that could reasonably be expected to have a material effect on the results of the Company’s operations. There are also no proceedings in which any of the Company’s directors, officers or affiliates is an adverse party or has a material interest adverse to the Company’s interest.
(b) | Contingencies |
The Company's operations are subject to a variety of local and state regulation. Failure to comply with one or more of those regulations could result in fines, restrictions on its operations, or losses of permits that could result in the Company ceasing operations. While management of the Company believes that the Company is in compliance with applicable local and state regulation at September 30, 2020, cannabis regulations continue to evolve and are subject to differing interpretations. As a result, the Company may be subject to regulatory fines, penalties, or restrictions in the future.
7. | RELATED PARTY TRANSACTIONS |
(a) | Transactions with related parties |
The Company purchases product from the several related parties, CitiMed LLC, Colorado Health Consultants, LLC and Starbuds MIPS LLC. In addition, the Company receives management, advisory and marketing support services from Star Packaging and Supply LLC. Amounts expensed and paid each related party were the following for the year ended December 31, 2019 and the nine months ended September 30, 2020 and 2019.
Year Ended | ||||||||||||
Nine Months Ended September 30, | December 31, | |||||||||||
2020 | 2019 | 2019 | ||||||||||
(unaudited) | (unaudited) | |||||||||||
CitiMed LLC | $ | 95,000 | $ | 45,000 | $ | 50,000 | ||||||
Colorado Health Consultants, LLC | 45,000 | 30,000 | 80,000 | |||||||||
Starbuds MIPS LLC | 134,000 | 170,000 | 235,000 | |||||||||
Star Packaging and Supply LLC | 93,000 | 90,000 | 115,000 | |||||||||
Total | $ | 367,000 | $ | 320,000 | $ | 440,000 |
Purchases from Starbuds MIPS LLC were approximately 11%, 6%, 10% of the Company’s purchases for the year ended December 31, 2019 and for the nine months ended September 30, 2020 and 2019, respectively.
The Company periodically sells inventory, at cost, to affiliate Starbuds stores. Product sales to affiliate stores were approximately $75,000 for the year ended December 31, 2019 and $10,000 and $70,000 for the nine months ended September 30, 2020 and 2019, respectively.
Star Brands, LLC provides the Company with the right to use the Starbuds brand and licensed property. The Company does not pay Star Brands LLC for the use of such assets. However, the Company recorded non-cash licensee expense of during the year ended December 31, 2019 and for the nine months ended September 30, 2020 and 2019 of approximately $452,000, $365,000 and $342,000, respectively.
25 |
LUCKY TICKET LLC
Notes to Financial Statements
For the Nine Months Ended September 30, 2020 and 2019 (unaudited)
And the Year Ended December 31, 2019
8. SUBSEQUENT EVENTS
Management has evaluated significant events or transactions that have occurred since the balance sheet date and through March 3, 2021, the date the financial statements were available to be issued.
The novel coronavirus commonly referred to as “COVID-19” was identified in December 2019 in Wuhan, China. On January 30, 2020, the World Health Organization declared the outbreak a global health emergency, and on March 11, 2020, the spread of COVID-19 was declared a pandemic by the World Health Organization. On March 13, 2020, the spread of COVID-19 was declared a national emergency. The outbreak has spread throughout the globe, causing companies and various international jurisdictions to impose restrictions such as quarantines, business closures and travel restrictions.
While these effects are expected to be temporary, the duration of the business disruptions and related financial impact cannot reasonably be estimated at this time. In addition, it is possible that estimates in the Company’s financial statements will change in the near term as a result of COVID-19 and the effect of any such changes could be material, which could result in, among other things, impairment of long-lived assets. The Company is closely monitoring the impact of the pandemic on all aspects of its business.
In response to the COVID-19 pandemic and government mandates, safety, social distancing and other physical workforce distancing protocols were implemented. Although the impact of the coronavirus on the Companies’ operations to date has not been significant, the ultimate impact of COVID-19 on the Companies will depend on future developments, which are highly uncertain and cannot be predicted, including new information which may emerge concerning the severity of COVID-19 and the actions required to contain the coronavirus or treat its impact, among others.
As described in Note 1, the Company was acquired by Medicine Man Technologies, Inc.
Subsequent to December 31, 2019, the Company distributed approximately $2,300,000 to its members.
26 |
Exhibit 99.2
Medicine Man Technologies, Inc.
Unaudited Pro Forma Condensed Combined Financial Information
The unaudited pro forma condensed combined balance sheet as of September 30, 2020 and the unaudited pro forma condensed combined statements of operations for each of the nine months ended September 30, 2020 and for the year ended December 31, 2019 combine the financial statements of Medicine Man Technologies, Inc. (“Medicine Man”), Commerce City, LLC (“Commerce City) and Lucky Ticket, LLC (“Lucky Ticket”)giving effect to the transaction described in the Agreements, as if they had occurred on January 1, 2019 in respect of the unaudited pro forma condensed combined statements of operations and on September 30, 2020 in respect of the unaudited pro forma condensed combined balance sheet.
The unaudited pro forma condensed combined financial information should be read in conjunction with:
· | Medicine Man’s audited consolidated financial statements and accompanying notes as of and for the year ended December 31, 2019, as contained in the Form 10-K filed on March 31, 2020 with the United States Securities and Exchange Commission (the “SEC”). |
· | Medicine Man’s unaudited condensed consolidated financial statements and accompanying notes as of and for the nine months ended September 30, 2020, as contained in its Quarterly Report on Form 10-Q filed on November 13, 2020 with the SEC. |
· | Commerce City and Lucky Ticket’s audited financial statements as of and for the year ended December 31, 2019, contained elsewhere herein. |
· | Commerce City and Lucky Ticket’s unaudited condensed financial statements as of September 30, 2020 and for the nine months ended September 30, 2020 and 2019, contained elsewhere herein. |
· | the other information contained in or incorporated by reference into this filing. |
The final purchase consideration and the allocation of the purchase consideration may materially differ from that reflected in the unaudited pro forma condensed combined financial information after final valuation procedures are performed and amounts are finalized following the completion of the acquisition.
The unaudited pro forma adjustments give effect to events that are directly attributable to the transaction and are based on available data and certain assumptions that management believes are factually supportable. In addition, with respect to the unaudited condensed combined statements of operations, the unaudited pro forma adjustments are expected to have a continuing impact on the combined results.
The unaudited pro forma condensed combined financial information is presented for informational purposes only and to aid you in your analysis of the financial aspects of the acquisition. The unaudited pro forma condensed combined financial information described above has been derived from the historical financial statements of Medicine Man, Commerce City, and Lucky Ticket and the related notes included elsewhere in this Form 8-K. The unaudited pro forma condensed combined financial information is based on Medicine Man’s accounting policies. Further review may identify additional differences between the accounting policies of Medicine Man, Commerce City, and Lucky Ticket. The unaudited pro forma adjustments and the pro forma condensed combined financial information do not reflect the impact of synergies or post-transaction management actions and are not necessarily indicative of the financial position or results of operations that may have actually occurred had the transaction taken place on the dates noted, or of Medicine Man’s future financial position or operating results.
1 |
Medicine Man Technologies, Inc.
Unaudited Pro Forma Condensed Combined Balance Sheet
September 30, 2020
Medicine Man | Lucky Ticket | Commerce City | Pro Forma Adjustments | Pro Forma Combined | |||||||||||||||||
ASSETS | |||||||||||||||||||||
Current assets: | |||||||||||||||||||||
Cash and cash equivalents | $ | 2,981,688 | $ | 148,250 | $ | 227,073 | $ | (375,323 | ) | (A) | $ | 2,982,888 | |||||||||
1,200 | (C) | ||||||||||||||||||||
Accounts receivable, net of allowance for doubtful accounts | 812,212 | – | – | – | 812,212 | ||||||||||||||||
Accounts receivable – related party | 91,990 | – | – | – | 91,990 | ||||||||||||||||
Inventory | 2,151,612 | 168,719 | 240,576 | – | 2,560,907 | ||||||||||||||||
Notes receivable – related party | 283,849 | – | – | – | 283,849 | ||||||||||||||||
Prepaid expenses and other current assets | 254,602 | – | 7,039 | (7,039 | ) | (A) | 254,602 | ||||||||||||||
Total current assets | 6,575,953 | 316,969 | 474,688 | (381,162 | ) | 6,986,448 | |||||||||||||||
Non-current assets: | |||||||||||||||||||||
Fixed assets, net | 2,719,154 | 73,618 | 313,144 | – | 3,105,916 | ||||||||||||||||
Goodwill | 17,445,843 | – | – | 18,870,436 | (C) | 36,316,279 | |||||||||||||||
Intangible assets, Net | 70,329 | – | – | – | 70,329 | ||||||||||||||||
Investment | 527,575 | – | – | – | 527,575 | ||||||||||||||||
Accounts receivable – litigation | 3,063,968 | – | – | – | 3,063,968 | ||||||||||||||||
Deferred tax assets, net | 268,423 | – | – | – | 268,423 | ||||||||||||||||
Notes receivable – noncurrent, net | 247,272 | – | – | – | 247,272 | ||||||||||||||||
Operating lease right of use assets | 1,650,117 | – | – | – | 1,650,117 | ||||||||||||||||
Other assets | 127,999 | 5,400 | – | (5,400 | ) | (A) | 127,999 | ||||||||||||||
Total non-current assets | 26,120,680 | 79,018 | 313,144 | 18,865,036 | 45,377,878 | ||||||||||||||||
Total assets | $ | 32,696,633 | $ | 395,987 | $ | 787,832 | $ | 18,483,874 | $ | 52,364,326 |
2 |
LIABILITIES AND STOCKHOLDERS' EQUITY | |||||||||||||||||||||
Checks issued in excess of bank balance | $ | – | $ | 18,529 | $ | – | $ | (18,529 | ) | (A) | $ | – | |||||||||
Accounts payable | 2,957,390 | – | 5,066 | (5,066 | ) | (A) | 2,957,390 | ||||||||||||||
Accounts payable – related party | 127,694 | – | – | – | 127,694 | ||||||||||||||||
Accrued expenses | 1,426,315 | 106,480 | 103,002 | (209,482 | ) | (A) | 1,426,315 | ||||||||||||||
Seller note payable | – | – | – | 5,919,319 | (B) | 6,921,214 | |||||||||||||||
Convertible note payable | – | – | – | 2,491,258 | (B) | 2,491,258 | |||||||||||||||
Derivative liabilities | 782,896 | – | – | – | 782,896 | ||||||||||||||||
Income taxes payable | – | – | – | – | – | ||||||||||||||||
Loyalty points liability | – | 130,000 | 80,000 | – | 210,000 | ||||||||||||||||
Total current liabilities | 5,294,295 | 255,009 | 188,068 | 8,177,500 | 13,914,872 | ||||||||||||||||
Noncurrent liabilities: | |||||||||||||||||||||
Lease liabilities | 1,684,005 | – | – | – | 1,684,005 | ||||||||||||||||
Total noncurrent liabilities | 1,684,005 | – | – | – | 1,684,005 | ||||||||||||||||
Total liabilities | 6,978,300 | 255,009 | 188,068 | 8,177,500 | 15,598,877 | ||||||||||||||||
Stockholders’ equity | |||||||||||||||||||||
Common stock $0.001 par value, 250,000,000 authorized, 42,194,878 shares issued and 41,762,146 shares outstanding at September 30, 2020, and 39,952,628 shares issued and outstanding at December 31, 2019. | 42,195 | – | – | – | 42,195 | ||||||||||||||||
Preferred Stock | 4,429,956 | (B) | 4,429,956 | ||||||||||||||||||
Additional paid-in capital | 60,714,343 | – | – | 6,617,160 | (B) | 67,331,503 | |||||||||||||||
Accumulated equity (deficit) | (33,705,705 | ) | 140,978 | 599,764 | (740,742 | ) | (A) | (33,705,705 | ) | ||||||||||||
Common stock held in treasury, at cost, 432,732 shares held at September 30, 2020 and 257,732 shares held at December 31, 2019 | (1,332,500 | ) | – | – | – | (1,332,500 | ) | ||||||||||||||
Total stockholders' equity | 25,718,333 | 140,978 | 599,764 | 10,306,374 | 36,765,449 | ||||||||||||||||
Total liabilities and stockholders’ equity | $ | 32,696,633 | $ | 395,987 | $ | 787,832 | $ | 18,483,874 | $ | 52,364,326 |
See notes to the unaudited pro forma condensed combined financial information.
3 |
Medicine Man Technologies, Inc.
Unaudited Pro Forma Condensed Combined Statement of Operations
For the Nine Months Ended September 30, 2020
Medicine Man | Lucky Ticket | Commerce City | Pro Forma Adjustments | Pro Forma Combined | |||||||||||||||||
Operating revenues: | |||||||||||||||||||||
Product sales, net | $ | 14,292,374 | $ | 4,562,094 | $ | 2,876,996 | $ | – | $ | 21,731,464 | |||||||||||
Product sales – related party, net | 484,930 | – | – | – | 484,930 | ||||||||||||||||
Consulting and licensing services | 1,267,587 | – | – | – | 1,267,587 | ||||||||||||||||
Other operating revenues | 12,946 | – | – | – | 12,946 | ||||||||||||||||
Total revenue | 16,057,837 | 4,562,094 | 2,876,996 | – | 23,496,927 | ||||||||||||||||
Cost of goods and services: | |||||||||||||||||||||
Cost of goods and services | 9,904,131 | 2,270,708 | 1,439,580 | – | 13,614,419 | ||||||||||||||||
Gross profit | 6,153,706 | 2,291,386 | 1,437,416 | – | 9,882,508 | ||||||||||||||||
Operating expenses: | |||||||||||||||||||||
Selling, general and administrative expenses | 3,054,091 | 854,062 | 644,373 | – | 4,552,526 | ||||||||||||||||
Professional services | 5,390,186 | – | – | – | 5,390,186 | ||||||||||||||||
Salaries, benefits and related expenses | 5,973,482 | – | – | – | 5,973,482 | ||||||||||||||||
Stock based compensation | 5,815,808 | – | – | – | 5,815,808 | ||||||||||||||||
Depreciation | – | 6,255 | 24,042 | – | 30,297 | ||||||||||||||||
Total operating expenses | 20,233,567 | 860,317 | 668,415 | – | 21,762,299 | ||||||||||||||||
Income from operations (loss) | (14,079,861 | ) | 1,431,069 | 769,001 | – | (11,879,791 | ) | ||||||||||||||
Other income (expense): | |||||||||||||||||||||
Gain on forfeiture of contingent consideration | 1,462,636 | – | – | – | 1,462,636 | ||||||||||||||||
Interest income (expense), net | 46,726 | – | – | (850,000 | ) | (E) | (803,274 | ) | |||||||||||||
Amortization of debt discount - warrants | – | – | – | (150,284 | ) | (F) | (150,284 | ) | |||||||||||||
Other income (expense) | 32,621 | – | – | – | 32,621 | ||||||||||||||||
Unrealized gain (loss) on derivative liabilities | 1,527,850 | – | – | – | 1,527,850 | ||||||||||||||||
Unrealized gain (loss) on investments | 120,800 | – | – | – | 120,800 | ||||||||||||||||
Total other income | 3,190,633 | – | – | (1,000,284 | ) | 2,190,349 | |||||||||||||||
Income (loss) before income tax expense | (10,889,228 | ) | 1,431,069 | 769,001 | (1,000,284 | ) | (7,689,442 | ) | |||||||||||||
Income tax benefit (expense) | – | – | – | (880,000 | ) | (D) | (880,000 | ) | |||||||||||||
Net income (loss) | $ | (10,889,228 | ) | $ | 1,431,069 | $ | 769,001 | $ | (1,880,284 | ) | $ | (10,569,442 | ) | ||||||||
Earnings (loss) per share attributable to common shareholders: | |||||||||||||||||||||
Weighted average number of shares outstanding - basic and diluted | 41,242,041 | – | – | 865,821 | 42,107,862 | ||||||||||||||||
Basic and diluted earnings (loss) per share | $ | (0.26 | ) | – | – | – | $ | (0.25 | ) |
See notes to the unaudited pro forma condensed combined financial information
4 |
Medicine Man Technologies, Inc.
Unaudited Pro Forma Condensed Combined Statement of Operations
For the Year Ended December 31, 2019
Medicine Man | Lucky Ticket | Commerce City | Pro Forma Adjustments | Pro Forma Combined | |||||||||||||||||
Operating revenues | |||||||||||||||||||||
Product sales, net | $ | 6,468,230 | $ | 5,656,049 | $ | 3,227,482 | $ | – | $ | 15,351,761 | |||||||||||
Product sales – related party, net | 1,351,578 | – | – | – | 1,351,578 | ||||||||||||||||
Litigation revenue | 1,782,457 | – | – | – | 1,782,457 | ||||||||||||||||
Licensing, consulting and Cultivation Max fees | 2,767,649 | – | – | – | 2,767,649 | ||||||||||||||||
Other operating revenues | 31,041 | – | – | – | 31,041 | ||||||||||||||||
Total operating revenues | 12,400,955 | 5,656,049 | 3,227,482 | – | 21,284,486 | ||||||||||||||||
Cost of goods and services | |||||||||||||||||||||
Cost of goods and services | 7,616,221 | 2,535,833 | 1,603,338 | – | 11,755,392 | ||||||||||||||||
Gross profit | 4,784,734 | 3,120,216 | 1,624,144 | – | 9,529,094 | ||||||||||||||||
Operating expenses | |||||||||||||||||||||
Selling, general and administrative | 2,199,609 | 1,055,354 | 839,174 | – | 4,094,137 | ||||||||||||||||
Professional services | 3,357,877 | – | – | – | 3,357,877 | ||||||||||||||||
Salaries, benefits and related expenses | 3,567,535 | – | – | – | 3,567,535 | ||||||||||||||||
Stock-based compensation | 7,279,363 | – | – | – | 7,279,363 | ||||||||||||||||
Depreciation and amortization expense | 61,708 | – | – | – | 61,708 | ||||||||||||||||
Derivative expense – contingent compensation | 5,400,559 | – | – | – | 5,400,559 | ||||||||||||||||
Depreciation | – | 7,714 | 31,988 | – | 39,702 | ||||||||||||||||
Total operating expenses | 21,866,651 | 1,063,068 | 871,162 | – | 23,800,881 | ||||||||||||||||
Income from operations (loss) | (17,081,917 | ) | 2,057,148 | 752,982 | – | (14,271,787 | ) | ||||||||||||||
Other income (expense) | |||||||||||||||||||||
Bad debt expense | (151,169 | ) | – | – | – | (151,169 | ) | ||||||||||||||
Amortization of debt discount - warrant | (200,379 | ) | (200,379 | ) | |||||||||||||||||
Unrealized gain on derivative liabilities | 1,627,177 | – | – | – | 1,627,177 | ||||||||||||||||
Unrealized loss on marketable securities | (1,792,569 | ) | – | – | – | (1,792,569 | ) | ||||||||||||||
Interest expense | (160,195 | ) | – | – | (1,130,000 | ) | (E) | (1,290,195 | ) | ||||||||||||
Total other expense | (476,756 | ) | – | – | (1,130,000 | ) | (1,807,135 | ) | |||||||||||||
Income (loss) before income tax expense | (17,558,673 | ) | 2,057,148 | 752,982 | (1,130,000 | ) | (16,078,922 | ) | |||||||||||||
Income tax benefit (expense) | 582,931 | – | – | (1,140,000 | ) | (D) | (557,069 | ) | |||||||||||||
Net (loss) income | $ | (16,975,742 | ) | $ | 2,057,148 | $ | 752,982 | $ | (2,470,379) | ) | $ | (16,635,991 | ) | ||||||||
Earnings (loss) per share attributable to common shareholders: | |||||||||||||||||||||
Weighted average number of shares outstanding - basic and diluted | 33,740,557 | – | – | 865,821 | 34,606,378 | ||||||||||||||||
Basic and diluted earnings (loss) per share | $ | (0.50 | ) | – | – | – | $ | (0.48 | ) |
See notes to the unaudited pro forma condensed combined financial information
5 |
Medicine Man Technologies, Inc.
Notes to Unaudited Pro Forma Condensed Combined Financial Information
Note 1. Basis of Presentation
The unaudited pro forma condensed combined financial information set forth herein is based upon the consolidated financial statements of Medicine Man Technologies, Inc., Commerce City, LLC and Lucky Ticket, LLC. The unaudited pro forma condensed combined financial information is presented as if the transaction had been completed on January 1, 2019 with respect to the unaudited pro forma condensed combined statements of operations for each of the nine months ended September 30, 2020 and for the year ended December 31, 2019 and on September 30, 2020 in respect of the unaudited pro forma condensed combined balance sheet.
The unaudited pro forma condensed combined financial information is presented for informational purposes only and is not necessarily indicative of the combined financial position or results of operations had the transaction occurred as of the dates indicated, nor is it meant to be indicative of any anticipated combined financial position or future results of operations that the combined company will experience after the completion of the transactions.
We have accounted for the acquisition in this unaudited pro forma condensed combined financial information using the acquisition method of accounting, in accordance with Financial Accounting Standards Board Accounting Standards Codification Topic 805 “Business Combinations” (“ASC 805”). In accordance with ASC 805, we use our best estimates and assumptions to assign fair value to the tangible and intangible assets acquired and liabilities assumed at the acquisition date. Goodwill as of the acquisition date is measured as the excess of purchase consideration over the fair value of net tangible and identifiable intangible assets acquired.
Pro forma adjustments reflected in the unaudited pro forma condensed combined balance sheet are based on items that are factually supportable and directly attributable to the transaction. Pro forma adjustments reflected in the pro forma condensed combined statements of operations are based on items that are factually supportable, directly attributable to the transaction and expected to have a continuing impact on the combined results. The unaudited pro forma condensed combined financial information does not reflect the cost of any integration activities or benefits from the transaction, including potential synergies that may be generated in future periods.
Note 2. Description of the Transaction
On December 17, 2020, Medicine Man Technologies, Inc. operating its business under the trade name Schwazze (the “Company”) consummated the Agreements with Commerce City and Lucky Ticket. The aggregate purchase price for both entities is $19,457,693, which comprised of cash, seller notes, and stock in Medicine Man, Inc. In December 2020, the Company acquired the net assets of four other companies, which are not included in the unaudited pro forma condensed financial information presented.
Note 3. Purchase Price Allocation
The fair value of the consideration transferred was valued as of the date of the acquisition as follows:
Commerce City, LLC and Lucky Ticket, LLC Purchase Consideration | ||||
Cash | $ | 6,921,214 | ||
Seller Notes | 6,921,214 | |||
Stockholders’ Equity | 5,615,265 | |||
Total Purchase Consideration | $ | 19,457,693 |
6 |
The preliminary allocation for the consideration recorded for the acquisition is as follows if the acquisition had taken place as of September 30, 2020:
Current Assets | $ | 410,495 | ||
Property and Equipment | 386,762 | |||
Goodwill | 18,870,436 | |||
Loyalty Points Liability | (210,000 | ) | ||
Total | $ | 19,457,693 |
The purchase price allocation is preliminary. The purchase price allocation will continue to be preliminary until a third-party valuation is finalized and the fair value and useful life of the assets acquired is determined. The amounts from the final valuation may significantly differ from the preliminary allocation.
Note 4. Pro Forma Adjustments
The following pro forma adjustments give effect to the transaction.
Unaudited Pro Forma Condensed Combined Balance Sheet – As of September 30, 2020
Note A | To remove Commerce City and Lucky Ticket assets, liabilities, and equity. |
Note B
|
To record purchase consideration and transaction financing.
The purchase consideration included cash, seller notes, and Medicine Man, Inc., stock. There were warrants associated with the seller notes that the Company determined required equity treatment. The exercise price was $1.20 per share and exercisable within five years from the acquisition date. The Company evaluated the warrants for liability or equity classification and concluded the warrants should be accounted for as equity. The Company determined the total fair value of the warrants to be $2,010,812, which will be amortized over the term of the notes. The warrant amount presented on the pro forma schedule of $1,001,895 was calculated based on a pro-rata allocation for Commerce City and Lucky Ticket.
The convertible note for $5,000,000, dated December 16, 2020, accrues interest at 12% per annum and matures in December 2021. If a Qualified Financing occurs on or prior to the Maturity Date or Holder receives a Prepayment Notice, then all (but not less than all) of the outstanding principal amount of this Promissory Note and Security Agreement and all accrued and unpaid interest on this Promissory Note and Security Agreement shall be convertible at the sole option of Holder into either (i) the securities issued in such Qualified Financing or (ii) shares of Maker’s Series A Cumulative Convertible Preferred Stock, par value $0.001 per share at the price per share equal to the price per share paid by the other investors in the Qualified Financing on the issuance as preferred stock, as applicable. The terms are further described in the convertible promissory note and security agreement. The convertible note amount presented on the pro forma schedule was calculated based on a pro-rata allocation for Commerce City and Lucky Ticket.
The Company sold an aggregate of 12,400 shares of the Company’s Series A preferred stock, par value $0.001 per share having the rights, preferences and privileges set forth in the securities purchase agreements, including the conversion of such Preferred Stock into shares of the Company’s common stock, par value $0.001 per share. Such purchase and sale of Preferred Stock shall take place in a single closing subject to the terms and conditions of this Agreement. The preferred stock amount presented on the pro forma schedule was calculated based on a pro-rata allocation for Commerce City and Lucky Ticket.
|
Note C | To record assets acquired and liabilities assumed from Commerce City and Lucky Ticket at preliminary estimated fair value. The Company has not completed its purchase price allocation and the amounts noted are preliminary. |
Unaudited Pro Forma Condensed Combined Statement of Operations – For The Nine Months Ended September 30, 2020
Note D | To record provision for income tax based on an estimated effective tax rate of 24% applied to income taxable under IRC Section 280E. |
Note E |
To record interest on seller note and convertible note payable of 12% per annum. |
Note F | To record amortization of debt discount related to warrant. The amortization amount presented on the pro forma schedule was calculated based on a pro-rata allocation for Commerce City and Lucky Ticket and a five year life. |
Unaudited Pro Forma Condensed Combined Statement of Operations – For The Year Ended December 31, 2019
Note D | To record provision for income tax based on an estimated effective tax rate of 24% applied to income taxable under IRC Section 280E. |
Note E | To record interest on seller note and convertible note payable of 12% per annum. |
Note F |
To record amortization of debt discount related to warrant. The amortization amount presented on the pro forma schedule was calculated based on a pro-rata allocation for Commerce City and Lucky Ticket and a five year life.
|
7 |